Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2020, Vol. 11 Issue (4) : 737-741     DOI: 10.14336/AD.2020.0518
Commentary |
COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?
Hipkiss Alan R*
Aston Research Centre for Healthy Ageing (ARCHA), Aston University, Birmingham, B4 7ET, UK
Download: PDF(257 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    

It is suggested that the non-toxic dipeptide carnosine (beta-alanyl-L-histidine) should be examined as a potential protective agent against COVID-19 infection and inflammatory consequences especially in the elderly. Carnosine is an effective anti-inflammatory agent which can also inhibit CD26 and ACE2 activity. It is also suggested that nasal administration would direct the peptide directly to the lungs and escape the attention of serum carnosinase.

Keywords carnosine      acetyl-carnosine      inflammation      virus      olfaction      lungs      aging     
Corresponding Authors: Hipkiss Alan R   
About author:

These authors contributed equally to this work.

Just Accepted Date: 20 May 2020   Issue Date: 30 July 2020
E-mail this article
E-mail Alert
Articles by authors
Hipkiss Alan R
Cite this article:   
Hipkiss Alan R. COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?[J]. Aging and disease, 2020, 11(4): 737-741.
URL:     OR
[1] Malavolta M, Giacconi R, Brunetti D, Provinciali M, Maggi F (2020). Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2. Emergency and Similar Future Global Health Threats. Cells, 9(4):E909.
[2] Lauc G, Sinclair D (2020). Biomarkers of biological age as predictors of COVID-19 disease severity. Aging, in press.
[3] Zhavoronkov A (2020). Geroprotective and Senoremediative Strategies to Reduce the Comorbidity, Infection Rates, Severity, and Lethality in Gerophilic and Gerolavic Infections. Aging, 12:6492-6510.
[4] Promislow DEL (2020). A geroscience perspective on COVID-19 mortality. J Gerontol A Biol Sci Med Sci, in press.
[5] McFarland GA, Holliday R (1994). Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res, 212(2):167-75.
[6] Stvolinsky S, Antipin M, Meguro K, Sato T, Abe H, Boldyrev AA (2010). Effect of carnosine and its Trolox-modified derivatives on life span of Drosophila melanogaster. Rejuvenation Res, 13(4):453-7.
[7] Yuneva AO, Kramarenko GG, Vetreshchak TV, Gallant S, Boldyrev AA (2002). Effect of carnosine on Drosophila melanogaster lifespan. Bull Exp Biol Med, 133(6):559-61
[8] Larroque-Cardoso P, Camaré C, Nadal-Wollbold F, Grazide MH, Pucelle M, Garoby-Salom S, et al. (2015). Elastin Modification by 4-Hydroxynonenal in Hairless Mice Exposed to UV-A. Role in Photoaging and Actinic Elastosis. J Invest Dermatol, 135(7):1873-1881.
[9] Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, et al. (2011). Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice. PLoS One, 6(3):e17971.
[10] Gallant S, Semyonova M, Yuneva M (2000). Carnosine as a potential anti-senescence drug. Biochemistry, 65(7):866-8.
[11] Aydın AF, Bingül İ, Küçükgergin C, Doğan-Ekici I, Doğru Abbasoğlu S, Uysal M (2017). Carnosine decreased oxidation and glycation products in serum and liver of high-fat diet and low-dose streptozotocin-induced diabetic rats. Int J Exp Pathol, 98(5):278-288.
[12] Bingül İ, Yılmaz Z, Aydın AF, Çoban J, Doğru-Abbasoğlu S, Uysal M (2017). Antiglycation and anti-oxidant efficiency of carnosine in the plasma and liver of aged rats. Geriatr Gerontol Int, 17(12):2610-2614.
[13] Xie Z, Baba SP, Sweeney BR, Barski OA (2013). Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications. Chem Biol Interact, 202(1-3):288-97
[14] Seidler NW, Yeargans GS (2002). Effects of thermal denaturation on protein glycation. Life Sci, 70(15):1789-99
[15] Hipkiss AR, Brownson C (2000). Carnosine reacts with protein carbonyl groups: another possible role for the anti-ageing peptide? Biogerontology, 1(3):217-23.
[16] Qu F, Xu W, Deng Z, Xie Y, Tang J, Chen Z, et al. (2020). Fish c-Jun N-Terminal Kinase (JNK) Pathway Is Involved in Bacterial MDP-Induced Intestinal Inflammation. Front Immunol, 11:459.
[17] Impellizzeri D, Siracusa R, Cordaro M, Peritore AF, Gugliandolo E, D'amico R, et al. (2020). Protective effect of a new hyaluronic acid -carnosine conjugate on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis. Biomed Pharmacother, 125:110023.
[18] Fresta CG, Fidilio A, Lazzarino G, Musso N, Grasso M, Merlo S, et al. (2020). Modulation of Pro-Oxidant and Pro-Inflammatory Activities of M1 Macrophages by the Natural Dipeptide Carnosine. Int J Mol Sci, 21(3):776.
[19] Fadda LM, Ali HM, Mohamed AM, Hagar H (2019). Prophylactic administration of carnosine and melatonin abates the incidence of apoptosis, inflammation, and DNA damage induced by titanium dioxide nanoparticles in rat livers. Environ Sci Pollut Res Int, in press.
[20] Caruso G, Fresta CG, Musso N, Giambirtone M, Grasso M, Spampinato SF, et al. (2019). Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1. Cells, 8:64.
[21] Tanaka KI, Kawahara M (2019). Carnosine and Lung Disease. Curr Med Chem, in press.
[22] Sun C, Wu Q, Zhang X, He Q, Zhao H (2017). Mechanistic Evaluation of the Protective Effect of Carnosine on Acute Lung Injury in Sepsis Rats. Pharmacol, 100(5-6):292-300.
[23] Tanaka KI, Sugizaki T, Kanda Y, Tamura F, Niino T, Kawahara M (2017). Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury. Sci Rep, 7:42813.
[24] Rothan HA, Abdulrahman AY, Khazali AS, Nor Rashid N, Chong TT, Yusof R (2019). Carnosine exhibits significant antiviral activity against Dengue and Zika virus. J Pept Sci, 25(8):e3196.
[25] Xu T, Wang C, Zhang R, Xu M, Liu B, Wei D, et al. (2015). Carnosine markedly ameliorates H9N2 swine influenza virus-induced acute lung injury. J Gen Virol, 96(10):2939-2950.
[26] Gallego M, Aristoy MC, Toldrá F (2014). Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham. Meat Sci, 96(2 Pt A):757-61
[27] Vahdatpour T, Nokhodchi A, Zakeri-Milani P, Mesgari-Abbasi M, Ahmadi-Asl N, Valizadeh H (2019). Leucine-glycine and carnosine dipeptides prevent diabetes induced by multiple low-doses of streptozotocin in an experimental model of adult mice. J Diabetes Investig, 10(5):1177-1188.
[28] Hou WC, Chen HJ, Lin YH (2003). Antioxidant peptides with Angiotensin converting enzyme inhibitory activities and applications for Angiotensin converting enzyme purification. J Agric Food Chem, 51(6):1706-9.
[29] Kilis-Pstrusinska K (2020). Carnosine and Kidney Diseases: What We Currently Know? Curr Med Chem, 27(11):1764-1781.
[30] Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD (2020). Covid-19 and co-morbidities: a role for Dipeptidyl Peptidase 4 (DPP4) in disease severity? J Diabetes, in press.
[31] Magrone T, Magrone M, Jirillo E (2020). Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective. Endocr Metab Immune Disord Drug Targets, in press.
[32] Hewlings S, Kalman D (2020). A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders. Nutrients, 12(3):665.
[33] Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, et al. (2020). Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med, in press.
[34] Mucha SR, Dugar S, McCrae K, Joseph DE, Bartholomew J, Sacha G, et al. (2020). Coagulopathy in COVID-19. Cleve Clin J Med, in press.
[35] Hipkiss AR (2019). Aging, Alzheimer's Disease and Dysfunctional Glycolysis; Similar Effects of Too Much and Too Little. Aging Dis, 10(6):1328-1331.
[36] Jacobson R, Mignemi N, Rose K, O'Rear L, Sarilla S, Hamm HE, et al. (2014). The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III. Thromb Res, 134(6):1350-7.
[37] Gugliucci A (2003). A practical method to study functional impairment of proteins by glycation and effects of inhibitors using current coagulation/ fibrinolysis reagent kits. Clin Biochem, 36; 155-158.
[38] Chaleckis R, Murakami I, Takada J, Kondoh H, Yanagida M (2016). Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci U S A, 113(16):4252-9.
[39] Kameda M, Teruya T, Yanagida M, Kondoh H (2020). Frailty markers comprise blood metabolites involved in antioxidation, cognition, and mobility. Proc Natl Acad Sci U S A, in press.
[40] Chao de la Barca JM, Rondet-Courbis B, Ferré M, Muller J, Buisset A, Leruez S, Plubeau G, et al. (2020). A Plasma Metabolomic Profiling of Exudative Age-Related Macular Degeneration Showing Carnosine and Mitochondrial Deficiencies. J Clin Med, 9(3):631
[41] Marinova Z, Maercker A, Grünblatt E, Wojdacz TK, Walitza S (2017). A pilot investigation on DNA methylation modifications associated with complex posttraumatic symptoms in elderly traumatized in childhood. BMC Res Notes, 10(1):752.
[42] McLaughlin KA, Colich NL, Rodman AM, Weissman DG (2020). Mechanisms linking childhood trauma exposure and psychopathology: a transdiagnostic model of risk and resilience. BMC Med, 18(1):96.
[43] Sallis HM, Croft J, Havdahl A, Jones HJ, Dunn EC, Davey Smith G, et al. (2020). Genetic liability to schizophrenia is associated with exposure to traumatic events in childhood. Psychol Med, 1:1-8.
[44] Ishida YI, Kayama T, Kibune Y, Nishimoto S, Koike S, Suzuki T, et al. (2017). Identification of an argpyrimidine-modified protein in human red blood cells from schizophrenic patients: A possible biomarker for diseases involving carbonyl stress. Biochem Biophys Res Commun, 493(1):573-577.
[45] Chengappa KN, Turkin SR, DeSanti S, Bowie CR, Brar JS, Schlicht PJ, et al. (2012). A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia. Schizophr Res, 142(1-3):145-52.
[46] Bordoni V, Sacchi A, Cimini E, Notari S, Grassi G, Tartaglia E, et al. (2020). An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19. Clin Infect Dis, in press.
[47] Izquierdo-Dominguez A, Rojas-Lechuga MJ, Mullol J, Alobid I (2020). Olfactory dysfunction in the COVID-19 outbreak. J Investig Allergol Clin Immunol, in press.
[48] Bonfanti L, Peretto P, De Marchis S, Fasolo A (1999). Carnosine-related dipeptides in the mammalian brain. Prog Neurobiol, 59(4):333-53.
[49] Baraniuk JN, El-Amin S, Corey R, Rayhan R, Timbol C (2013). Carnosine treatment for gulf war illness: a randomized controlled trial. Version 2. Glob J Health Sci, 4;5(3):69-81.
[50] Menon K, Marquina C, Liew D, Mousa A, de Courten B (2020). Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trials. Obes Rev, 21(3):e12975.
[51] Menini S, Iacobini C, Fantauzzi CB, Pugliese G (2020). L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes. Curr Med Chem, 27(11):1744-1763.
[52] Masuoka N, Yoshimine C, Hori M, Tanaka M, Asada T, Abe K et al. (2019). Effects of Anserine/Carnosine Supplementation on Mild Cognitive Impairment with APOE4. Nutrients, 11(7):1626.
[53] Chez MG, Buchanan CP, Aimonovitch MC, Becker M, Schaefer K, Black C, et al. (2002). Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol, 17(11):833-7.
[54] Hajizadeh-Zaker R, Ghajar A, Mesgarpour B, Afarideh M, Mohammadi MR, Akhondzadeh S (2018). L-Carnosine as an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. J Child Adolesc Psychopharmacol, 28(1):74-81.
[55] Lombardi C, Carubelli V, Lazzarini V, Vizzardi E, Bordonali T, Ciccarese C, et al. (2015). Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition, 31(1):72-8.
[56] Rodriguez-Niño A, Hauske SJ, Herold A, Qiu J, van den Born J, Bakker SJL, et al. (2019). Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease. J Diabetes Res, in press.
[57] Bauer K (2005). Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain. Neurochem Res, 30(10):1339-45.
[58] Chmielewska K, Dzierzbicka K, Inkielewicz-Stępniak I, Przybyłowska M (2020). Therapeutic Potential of Carnosine and Its Derivatives in the Treatment of Human Diseases. Chem Res Toxicol, in press.
[59] Hipkiss AR, Baye E, de Courten B (2016). Carnosine and the processes of ageing. Maturitas, 93:28-33.
[1] Barzilai Nir,Appleby James C,Austad Steven N,Cuervo Ana Maria,Kaeberlein Matt,Gonzalez-Billault Christian,Lederman Stephanie,Stambler Ilia,Sierra Felipe. Geroscience in the Age of COVID-19[J]. Aging and disease, 2020, 11(4): 725-729.
[2] Pedro C Lara, Nam P Nguyen, David Macias-Verde, Javier Burgos-Burgos, Meritxell Arenas, Alice Zamagni, Vincent Vinh-Hung, Brigitta G Baumert, Micaela Motta, Arthur Sun Myint, Marta Bonet, Tiberiu Popescu, Te Vuong, Gokula Kumar Appalanaido, Lurdes Trigo, Ulf Karlsson, Juliette Thariat. Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group[J]. Aging and disease, 2020, 11(3): 489-493.
[3] Janina Tiemann, Thomas Wagner, Olivier M Vanakker, Matthias van Gils, José-Luis Bueno Cabrera, Bettina Ibold, Isabel Faust, Cornelius Knabbe, Doris Hendig. Cellular and Molecular Biomarkers Indicate Premature Aging in Pseudoxanthoma Elasticum Patients[J]. Aging and disease, 2020, 11(3): 536-546.
[4] Seong Gak Jeon, Anji Yoo, Dong Wook Chun, Sang Bum Hong, Hyunju Chung, Jin-il Kim, Minho Moon. The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis[J]. Aging and disease, 2020, 11(3): 705-724.
[5] Xiaoheng Li, Yajin Liao, Yuan Dong, Shuoshuo Li, Fengchao Wang, Rong Wu, Zengqiang Yuan, Jinbo Cheng. Mib2 Deficiency Inhibits Microglial Activation and Alleviates Ischemia-Induced Brain Injury[J]. Aging and disease, 2020, 11(3): 523-535.
[6] Tae H Ban, Eun N Kim, Min Y Kim, Ji H Lim, Jong H Lee, Hyung D Kim, Hye E Yoon, Cheol W Park, Bum S Choi. Renoprotective Effect of a Dipeptidyl Peptidase-4 Inhibitor on Aging Mice[J]. Aging and disease, 2020, 11(3): 588-602.
[7] Hyun-Doo Song, Sang Nam Kim, Abhirup Saha, Sang-Yeop Ahn, Seun Akindehin, Yeonho Son, Yoon Keun Cho, MinSu Kim, Ji-Hyun Park, Young-Suk Jung, Yun-Hee Lee. Aging-Induced Brain-Derived Neurotrophic Factor in Adipocyte Progenitors Contributes to Adipose Tissue Dysfunction[J]. Aging and disease, 2020, 11(3): 575-587.
[8] Pietro Gentile, Aris Sterodimas. Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease[J]. Aging and disease, 2020, 11(3): 465-469.
[9] Xiaotian Dong, Mengyan Wang, Shuangchun Liu, Jiaqi Zhu, Yanping Xu, Hongcui Cao, Lanjuan Li. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)[J]. Aging and disease, 2020, 11(3): 642-648.
[10] Sadanand Fulzele, Bikash Sahay, Ibrahim Yusufu, Tae Jin Lee, Ashok Sharma, Ravindra Kolhe, Carlos M Isales. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile[J]. Aging and disease, 2020, 11(3): 509-522.
[11] Hong Liu, Shiyan Chen, Min Liu, Hao Nie, Hongyun Lu. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis[J]. Aging and disease, 2020, 11(3): 668-678.
[12] Sunil S Adav, Siu Kwan Sze. Hypoxia-Induced Degenerative Protein Modifications Associated with Aging and Age-Associated Disorders[J]. Aging and disease, 2020, 11(2): 341-364.
[13] Ming Dong, Ziyi Yang, Hongcheng Fang, Jiaqing Xiang, Cong Xu, Yanqing Zhou, Qianying Wu, Jie Liu. Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction[J]. Aging and disease, 2020, 11(2): 365-376.
[14] Piotr Gronek, Dariusz Wielinski, Piotr Cyganski, Andrzej Rynkiewicz, Adam Zając, Adam Maszczyk, Joanna Gronek, Robert Podstawski, Wojciech Czarny, Stefan Balko, Cain CT. Clark, Roman Celka. A Review of Exercise as Medicine in Cardiovascular Disease: Pathology and Mechanism[J]. Aging and disease, 2020, 11(2): 327-340.
[15] Wanqing Sun, Yishi Wang, Yang Zheng, Nanhu Quan. The Emerging Role of Sestrin2 in Cell Metabolism, and Cardiovascular and Age-Related Diseases[J]. Aging and disease, 2020, 11(1): 154-163.
Full text



Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail:
Powered by Beijing Magtech Co. Ltd